Dr. Robbins is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
6550 Fannin Street
Smith 1001
Houston, TX 77030Phone+1 713-441-6640Fax+1 713-790-2797- Is this information wrong?
Summary
- Dr. Richard Robbins is an endocrinologist in Houston, TX. He is Chairman of Medicine at Houston Methodist Hospital and holds the Charles Duncan Presidential Distinguished Chair. Rich is also Senior Investigator at the HM Research Institute and Professor of Medicine at Weill Cornell Medicine and Texas A&M College of Medicine. He received his medical degree from Creighton University School of Medicine and has been in practice 41 years. He specializes in endocrine oncology, especially thyroid cancer.
Education & Training
- Tufts Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1981
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1975 - 1978
- Creighton University School of MedicineClass of 1975
- Columbia University Vagelos College of Physicians and SurgeonsNo Degree, 1970 - 1971
- University of DaytonB.S., 1966 - 1970
Certifications & Licensure
- TX State Medical License 2006 - 2024
- NY State Medical License 1976 - 2008
- CT State Medical License 1985 - 1994
- CO State Medical License 1981 - 1985
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- GME Exemplary Faculty Teaching “Apple” Award 2014
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Distinguished Service Award The Pituitary Society, 1995
- Join now to see all
Publications & Presentations
PubMed
- Persistent or Recurrent Disease in Thyroid Cancer Survivors Who Have Elevated Serum Antithyroglobulin Antibodies.Richard J Robbins, Trisha D Cubb, Maleeha Zahid, Jiaqiong Xu> ;Endocrine Practice. 2023 Jun 1
- MEN1 in a Patient With Nonsyndromic Familial Nonmedullary Thyroid Carcinoma.Lauren A Fitzgerald, Shelley Williamson, Jawairia Shakil, Robbins, R.> ;JCEM Case Reports. 2023 Jan 1
- Myxedema Coma Associated with Macroprolactinoma: Case Report and Review of the Literature.Elizabeth Jasola Omoniyi, Richard J Robbins> ;Case Reports in Endocrinology. 2022 Jan 1
- Join now to see all
Journal Articles
- The Costs of Training Internal Medicine Residents in the USBen-Ari R, Pindiprolu S, Goldman A, Parsons PE., Amer. J. Med., 1/1/2014
- Five Year Survival Is Similar In Thyroid Cancer Patients With Distant Metastases Prepared For Radioactive Iodine Therapy With Either Thyroid Hormone Withdrawal Or Reco...Tala H, Fagin J, Larson SM, Tuttle RM, J Clin Endo Metab., 1/1/2011
- Hürthle Cell Carcinoma of the Thyroid presenting as thyrotoxicosisKaranchi H, Hamilton DJ, Endo. Pract, 1/1/2011
- Join now to see all
Books/Book Chapters
Other
- Guidelines for the Diagnosis and Management of Differentiated Thyroid CarcinomaRobbins RJ, The PIER Project of the American College of Physicians
www.acponline.org
1/1/2001
Press Mentions
- Curiosity Prevails: A Conversation with Robert H. Eckel, MDSeptember 12th, 2021
Hospital Affiliations
- Houston Methodist HospitalHouston, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: